Your browser doesn't support javascript.
loading
Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER).
Rummelt, Christoph; Grishina, Olga; Schmoor, Claudia; Crysandt, Martina; Heuser, Michael; Götze, Katharina S; Schlenk, Richard F; Döhner, Konstanze; Salih, Helmut R; Heil, Gerhard; Müller-Tidow, Carsten; Brugger, Wolfram; Kündgen, Andrea; De Wit, Maike; Giagounidis, Aristoteles; Scholl, Sebastian; Neubauer, Andreas; Krauter, Jürgen; Bug, Gesine; Al-Ali, Haifa Kathrin; Wäsch, Ralph; Becker, Heiko; May, Annette M; Duyster, Justus; Hackanson, Björn; Ganser, Arnold; Döhner, Hartmut; Lübbert, Michael.
Afiliação
  • Rummelt C; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.
  • Grishina O; Clinical Trials Unit, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.
  • Schmoor C; Clinical Trials Unit, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.
  • Crysandt M; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen University, Aachen.
  • Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover.
  • Götze KS; Department of Medicine III, Technical University of Munich, Munich, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Munich, München.
  • Schlenk RF; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; National Center of Tumor Diseases, NCT-Trial Center, German Cancer Research Center, Heidelberg.
  • Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm.
  • Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tuebingen.
  • Heil G; Department of Hematology/Oncology, Klinikum Luedenscheid, Luedenscheid.
  • Müller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Heidelberg, Heidelberg, Germany; Department of Medicine A, University Hospital of Münster, Münster.
  • Brugger W; Department of Hematology, Hospital Villingen-Schwenningen, Villingen-Schwenningen.
  • Kündgen A; Department of Hematology, Oncology and Clinical Immunology, Heinrich- Heine-University, Faculty of Medicine, Düsseldorf, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Düsseldorf, Düsseldorf.
  • De Wit M; Department of Hematology and Oncology, Vivantes Klinikum Neukölln, Berlin.
  • Giagounidis A; Clinic for Oncology, Hematology and Palliative Medicine, Marien-Hospital Düsseldorf, Düsseldorf.
  • Scholl S; Department of Hematology and Oncology, Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena.
  • Neubauer A; Department of Hematology and Oncology, University Clinic Gießen/Marburg, Marburg.
  • Krauter J; Department of Internal Medicine III, Städtisches Klinikum Braunschweig, Braunschweig.
  • Bug G; Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Frankfurt, Frankfurt.
  • Al-Ali HK; Krukenberg Cancer Center, University Hospital Halle, Halle.
  • Wäsch R; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.
  • Becker H; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Freiburg, Freiburg.
  • May AM; Institute for Surgical Pathology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.
  • Duyster J; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Freiburg, Freiburg.
  • Hackanson B; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Hematology/Oncology, Universitätsklinikum Augsburg, Augsburg.
  • Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover.
  • Döhner H; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg.
  • Lübbert M; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg. michael.luebbert@uniklinik-freiburg.de.
Haematologica ; 108(8): 2244-2248, 2023 08 01.
Article em En | MEDLINE | ID: mdl-36601981
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article